Sundaram Senthil Vel
- SEC CIK
- 0001762316
No open-market purchases or sales filed in the past year.
Current role at each company
- TERN Terns Pharmaceuticals, Inc.Chief Executive Officeras of Jun 2, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sundaram Senthil Vel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2023 (view filing) | May 31 | 2 days | Sundaram Senthil VelChief Executive Officer | PPurchase | +2.11K | $1.41 | +$2.98K | +27.6%9.77K after | |
| Feb 3, 2023 (view filing) | Nov 30, 2022 | 65 daysLate | Sundaram Senthil VelChief Executive Officer | PPurchase | +3 | $1.41 | +$4.23 | 0.0%7.66K after | |
| Jun 8, 2022 (view filing) | May 31 | 8 daysLate | Sundaram Senthil VelChief Executive Officer | PPurchase | +7.66K | $1.47 | +$11.3K | New position7.66K after |